HK1205516A1 - Aminosteroids for the treatment of a ptp1b associated disease ptp1b - Google Patents

Aminosteroids for the treatment of a ptp1b associated disease ptp1b

Info

Publication number
HK1205516A1
HK1205516A1 HK15106046.4A HK15106046A HK1205516A1 HK 1205516 A1 HK1205516 A1 HK 1205516A1 HK 15106046 A HK15106046 A HK 15106046A HK 1205516 A1 HK1205516 A1 HK 1205516A1
Authority
HK
Hong Kong
Prior art keywords
ptp1b
aminosteroids
treatment
associated disease
disease
Prior art date
Application number
HK15106046.4A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Mclane
Inez Ruiz-White
W Lee Maloy
Henry R Wolfe
Original Assignee
Ohr Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohr Pharmaceutical Inc filed Critical Ohr Pharmaceutical Inc
Publication of HK1205516A1 publication Critical patent/HK1205516A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15106046.4A 2012-04-20 2015-06-25 Aminosteroids for the treatment of a ptp1b associated disease ptp1b HK1205516A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636252P 2012-04-20 2012-04-20
PCT/US2013/037330 WO2013158970A2 (en) 2012-04-20 2013-04-19 Aminosteroids for the treatment of a ptp1b associated disease

Publications (1)

Publication Number Publication Date
HK1205516A1 true HK1205516A1 (en) 2015-12-18

Family

ID=48325893

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106046.4A HK1205516A1 (en) 2012-04-20 2015-06-25 Aminosteroids for the treatment of a ptp1b associated disease ptp1b

Country Status (16)

Country Link
US (5) US9546194B2 (xx)
EP (2) EP2838907B1 (xx)
JP (4) JP6165843B2 (xx)
KR (3) KR102057812B1 (xx)
AU (3) AU2013249111B2 (xx)
CA (1) CA2870671C (xx)
DK (1) DK2838907T3 (xx)
ES (1) ES2736310T3 (xx)
HK (1) HK1205516A1 (xx)
HR (1) HRP20191348T1 (xx)
HU (1) HUE044769T2 (xx)
MX (2) MX367255B (xx)
PL (1) PL2838907T3 (xx)
PT (1) PT2838907T (xx)
TR (1) TR201911039T4 (xx)
WO (1) WO2013158970A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102057812B1 (ko) * 2012-04-20 2019-12-19 오에이치알 파마서티컬, 인코포레이티드 Ptp1b 연관 질병의 치료용 아미노스테로이드
US10040817B2 (en) * 2013-10-03 2018-08-07 Enterin Laboratories, Inc. Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
MA50094A (fr) * 2017-09-08 2020-07-15 Enterin Inc Méthodes de traitement des troubles du sommeil, des perturbations du sommeil et de symptômes associés à l'aide de compositions d'aminostérol
CN107802626B (zh) * 2017-10-11 2020-01-21 南昌大学 降血糖组合物及其制备方法、用途
CA3081815A1 (en) * 2017-11-06 2019-05-09 Cold Spring Harbor Laboratory Method and compositions for forming a copper-containing complex and uses thereof
EP3773600A4 (en) * 2018-03-27 2021-12-29 Enterin, Inc. Methods and compositions for treating hallucinations and conditions related to the same
CA3110049A1 (en) * 2018-07-20 2020-01-23 Cold Spring Harbor Laboratory (pyridinylmethyl)butanediamine derivatives that chelate copper
JP2022543244A (ja) * 2019-08-02 2022-10-11 エンターイン、 インコーポレイテッド ヒトスクアラミン誘導体、それを含む関連組成物、およびそれを用いた方法
CA3149479A1 (en) * 2019-08-02 2021-02-11 Enterin, Inc. Human aminosterol ent-03 compounds, related compositions comprising the same, and methods of using the same
WO2023230593A1 (en) 2022-05-27 2023-11-30 Cold Spring Harbor Laboratory Ptp1b inhibitors for treating lung injury

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2403683A (en) * 1942-04-25 1946-07-09 Relchstein Tadeus Compounds of the cyclopentanopolyhydrophenanthrene series and process of making same
US3636210A (en) * 1968-02-02 1972-01-18 Merck & Co Inc Cholanic acid and cholenic acid compositions and method of treatment
JPS60181096A (ja) * 1984-02-28 1985-09-14 Tokyo Tanabe Co Ltd 胆汁酸の精製方法
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
AU6392894A (en) * 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
ES2123133T3 (es) * 1993-03-10 1999-01-01 Magainin Pharma Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
DE69631527T2 (de) 1995-06-07 2004-09-23 Genaera Corp. Aminosterinverbindungen als inhibitoren der natrium/proton-pump, pharmazeutische methoden und präparaten davon
US7410959B1 (en) * 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
WO2001019830A1 (en) 1999-09-10 2001-03-22 Novo Nordisk A/S MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
ATE309250T1 (de) 1999-09-10 2005-11-15 Novo Nordisk As Modulatoren der protein tyrosin phosphatase (ptpases)
AU7476800A (en) 1999-09-10 2001-04-10 Novo Nordisk A/S Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
AU784795B2 (en) * 1999-12-09 2006-06-22 Genaera Corporation Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO2004058795A1 (en) * 2002-12-24 2004-07-15 The University Of British Columbia Angiogenic compounds and uses thereof
JP2006165843A (ja) * 2004-12-06 2006-06-22 Matsushita Electric Ind Co Ltd 画像処理装置
US20080058300A1 (en) * 2006-04-21 2008-03-06 Mclane Michael Induction of weight loss and the selective inhibition of PTP1B
EP3293195A1 (en) 2007-09-06 2018-03-14 OHR Pharmaceutical, Inc. Compounds for use in treating diabetes
KR101260221B1 (ko) * 2011-12-01 2013-05-06 주식회사 엘지화학 마스크
KR102057812B1 (ko) * 2012-04-20 2019-12-19 오에이치알 파마서티컬, 인코포레이티드 Ptp1b 연관 질병의 치료용 아미노스테로이드

Also Published As

Publication number Publication date
JP2021073250A (ja) 2021-05-13
US20200270300A1 (en) 2020-08-27
US10556923B2 (en) 2020-02-11
JP2015514781A (ja) 2015-05-21
JP6457010B2 (ja) 2019-01-23
AU2018256561A1 (en) 2018-11-22
US11434257B2 (en) 2022-09-06
JP6165843B2 (ja) 2017-07-19
EP3556765B1 (en) 2022-02-23
WO2013158970A2 (en) 2013-10-24
US20230203088A1 (en) 2023-06-29
EP2838907B1 (en) 2019-05-22
EP2838907A2 (en) 2015-02-25
JP2017178951A (ja) 2017-10-05
JP2019059781A (ja) 2019-04-18
HUE044769T2 (hu) 2019-11-28
AU2020203736A1 (en) 2020-06-25
CA2870671C (en) 2020-05-12
PT2838907T (pt) 2019-08-05
AU2013249111B2 (en) 2018-08-09
MX367255B (es) 2019-08-12
EP3556765A1 (en) 2019-10-23
KR20150003798A (ko) 2015-01-09
MX2014012619A (es) 2015-01-15
KR101963312B1 (ko) 2019-03-28
AU2020203736B2 (en) 2021-12-02
AU2013249111A1 (en) 2014-11-06
US9546194B2 (en) 2017-01-17
DK2838907T3 (da) 2019-08-05
WO2013158970A3 (en) 2013-12-12
US20190202858A1 (en) 2019-07-04
US20150099727A1 (en) 2015-04-09
AU2018256561B2 (en) 2020-03-05
KR20160091435A (ko) 2016-08-02
CA2870671A1 (en) 2013-10-24
PL2838907T3 (pl) 2019-12-31
US20170129914A1 (en) 2017-05-11
TR201911039T4 (tr) 2019-08-21
MX2019009539A (es) 2019-09-26
KR102057812B1 (ko) 2019-12-19
HRP20191348T1 (hr) 2019-10-18
ES2736310T3 (es) 2019-12-27
KR20190034685A (ko) 2019-04-02

Similar Documents

Publication Publication Date Title
HK1205516A1 (en) Aminosteroids for the treatment of a ptp1b associated disease ptp1b
GB201120345D0 (en) Medical console
ZA201305897B (en) Combination therapy
EP2740419A4 (en) TREATMENT INSTRUMENT
GB201321559D0 (en) Diagnosis of the condition of apparatus
EP2800530A4 (en) TRANSFORMERS FOR HISTOTRIPSIA THERAPY
ZA201400120B (en) Combination therapy
EP2740420A4 (en) THERAPEUTIC TOOL
GB2508667B (en) Diagnosis of the condition of apparatus
GB201217704D0 (en) Therapeutic agents
EP2883547A4 (en) MEDICINE
EP2701744A4 (en) COMBINATION THERAPY
GB201207305D0 (en) Therapy
HK1200723A1 (en) Pharmaceutical diagnostic
GB201505622D0 (en) Patient reported outcome instrument
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
HK1210474A1 (en) Therapeutic bisphosphonates
EP2704731A4 (en) TREATMENT OF AVIAN ORIGIN
GB201106981D0 (en) Compounds for the treatment of clostridium difficle-associated disease
GB201114226D0 (en) Combination therapy
GB201223021D0 (en) Therapeutic agents
IL222594A0 (en) Combined treatment utilizing vb-201
GB201212512D0 (en) Therapeutic agents
GB201210233D0 (en) Therapeutic agents
GB201204645D0 (en) Treatment of disease